Generic and brand-name drugs K

Generic and brand-name drugs K: Composition, drug form and content, indications, contraindications, precautions, unwanted effects, dosage and administration, interactions, storage

Komix: Relieve cough, the common cold, nasal congestion

Komix: Helps relieve cough with secretions or not, the common cold, nasal congestion due to allergies, or other causes.

Klacid MRL: Respiratory tract infection. Mild-moderate skin & soft tissue infections.

Contraindicated with hypersensitivity to macrolides or any of the excipients, concomitant use of astemizole, cisapride, pimozide, terfenadine, ergotamine/dihydroergotamine, lovastatin/simvastatin, colchicine.

Klacid Suspension: Respiratory, skin infections. Acute otitis. Mycobacterium infection.

Klacid Suspension: Respiratory, skin & skin structure infections. Acute otitis media. Mycobacterium infection. 

Keppra monotherapy

Keppra monotherapy: Partial-onset epilepsy with or without secondary generalization in adults & adolescents ≥16 years of age, newly diagnosed epilepsy.

Kernhistine: Medicine to treat Meniere syndrome

Kernhistine: Medicine to treat Meniere's syndrome (dizziness with nausea/vomiting, difficulty hearing or hearing loss, tinnitus). Symptoms of vestibular vertigo (dizziness with nausea or vomiting, even when standing still).

Kadcyla: Medicine to treat breast cancer

Initiate infusion over 90 minutes, monitor patient, during infusion and for at least 90 minutes after infusion. If it is well tolerated, subsequent doses can be infused within 30 minutes

Keytruda: Medicine to treat lung cancer

Common anemia, hypothyroidism; decreased appetite; headache, dizziness, taste disturbance, dry eyes; shortness of breath.

Klevaflu: New generation of antifungal drug

Intravenous infusion, rate not to exceed 10 mL per minute, considering infusion rate in patients on sodium or fluid restricted regimens

Komboglyze XR: antidiabetic drug

Komboglyze XR is indicated as an adjunct to diet and exercise for glycemic control in patients 18 years of age and older with type 2 diabetes mellitus not adequately controlled after a maximally tolerated dose of metformin monotherapy.